Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: J Immunol. 2011 Mar 25;186(9):5367–5375. doi: 10.4049/jimmunol.1003438

Table 1.

Relatively minor changes in hematopoietic cells in low-dose LPS-treated mice

Cells Control LPS
Total BM (1 femur) 23.6 ±3.7 × 106 24.7 ±4.0 × 106
Total SPL 1.61 ±0.3 × 108 2.8 ±0.9 × 108*
Total Thymus 1.33 ±0.3 × 108 1.01 ±0.2 × 108
# Myeloid / femur 9.76 ±0.03 × 106 13.5 ±0.08 × 106*
# Pre-B / femur 6.58 ±0.1.8 × 105 2.5 ±0.9 × 105*
# cDC / femur 3.5 ±0.2 × 104 5.9 ±1.1 × 104*
# B cells / spleen 6.0 ±2.1 × 10′ 11.7 ±0.8 × 10′*
# cDC / spleen 3.0 ±0.9 × 106 5.6 ±1.1 × 106*
# Myeloid / spleen 25.0 ±6.8 × 106 34.5 ±4.8 × 106*

cDC were gated as CD19B220CD11b+ CD11c+

Myeloid cells were gated as CD11b+ Gr-1+

Pre-B were gated as B220+ CD43IgM−/lo

Representative of 4 experiments with at least 4 mice per group per experiment

*

p<0.05 as determined by t-test